Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS). [electronic resource]
- Calcified tissue international Dec 2009
- 484-93 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1432-0827
10.1007/s00223-009-9299-6 doi
Aged Back Pain--epidemiology Bone Density Conservation Agents--therapeutic use Europe Female Fractures, Bone--epidemiology Humans Osteoporosis, Postmenopausal--complications Pain Measurement Quality of Life Teriparatide--therapeutic use Time Factors